Spots Global Cancer Trial Database for gestational trophoblastic neoplasia
Every month we try and update this database with for gestational trophoblastic neoplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6 | NCT06028672 | Gestational Tro... | Toripalimab Actinomycin-D | 18 Years - 60 Years | Peking Union Medical College Hospital | |
| Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy | NCT04812002 | Gestational Tro... | PD-1 inhibitor，... | 18 Years - 75 Years | Women's Hospital School Of Medicine Zhejiang University | |
| A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | NCT05635344 | Gestational Tro... Gestational Tro... Gestational Tro... | Pembrolizumab | 18 Years - | Imperial College London | |
| A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | NCT05635344 | Gestational Tro... Gestational Tro... Gestational Tro... | Pembrolizumab | 18 Years - | Imperial College London | |
| Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia | NCT03703271 | Gestational Tro... | Methotrexate hysteroscopic r... | 12 Years - 60 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) | NCT02664961 | Gestational Tro... Choriocarcinoma Placental Site ... Epithelioid Tro... | TRC105 Bevacizumab | 16 Years - 99 Years | Tracon Pharmaceuticals Inc. | |
| Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia | NCT05139095 | Gestational Tro... | Camrelizumab pl... Camrelizumab pl... | 18 Years - 60 Years | Peking Union Medical College Hospital | |
| The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment | NCT06169644 | Gestational Tro... | 16 Years - 55 Years | Sheffield Teaching Hospitals NHS Foundation Trust | ||
| Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia | NCT01823315 | Gestational Tro... Gestational Tro... Gestational Tro... Gestational Tro... | MTX 1 MTX 2 Act-d | 18 Years - 60 Years | Huazhong University of Science and Technology | |
| Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | NCT04562558 | Gestational Tro... Gestational Tro... Stage I Gestati... Stage II Gestat... Stage III Gesta... Invasive Mole Choriocarcinoma | Methotrexate Leucovorin Dactinomycin | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia | NCT05139095 | Gestational Tro... | Camrelizumab pl... Camrelizumab pl... | 18 Years - 60 Years | Peking Union Medical College Hospital | |
| Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | NCT04562558 | Gestational Tro... Gestational Tro... Stage I Gestati... Stage II Gestat... Stage III Gesta... Invasive Mole Choriocarcinoma | Methotrexate Leucovorin Dactinomycin | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia | NCT04756713 | Gestational Tro... Molar Pregnancy Gestational Tro... | Uterine curetta... Chemotherapy | - | Brigham and Women's Hospital | |
| The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment | NCT06169644 | Gestational Tro... | 16 Years - 55 Years | Sheffield Teaching Hospitals NHS Foundation Trust | ||
| Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia | NCT05405192 | Gestational Tro... | Dostarlimab | 18 Years - | University of Miami | |
| Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia | NCT03703271 | Gestational Tro... | Methotrexate hysteroscopic r... | 12 Years - 60 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia | NCT04756713 | Gestational Tro... Molar Pregnancy Gestational Tro... | Uterine curetta... Chemotherapy | - | Brigham and Women's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
